| Name | Title | Contact Details |
|---|
Eastern States Eyewear is a Elmont, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ARC Devices is a wireless, non-contact, vital signs and medical devices monitor innovator. Founded in 2012 we create world class vital signs monitors and medical devices for clinical professionals as well as responsible consumers; ensuring that you recieve the latest benefits of the personal health-care revolution. With an ever increasing awareness of health care becoming an essential element of modern life we take pride in our reputation for excellence and originality, maintaining the highest industry standards in both our products and our consumer service. By focusing on creativity, imagination, and invention we push the boundaries of technology to meet your needs in an increasingly fast paced, health concious, world. From family friendly, non-contact thermometers, to futuristic vital signs monitors, we create easy-to-use precision instruments which are small enough to fit in the palm of your hand. As the global medical revolution gains pace the team at Arc Designs continues to innovate and take the first leaps towards the next generation of personalized healthcare. We believe in a better future and so we look to the stars to improve the ground on which you stand.
Power Medical Interventions, Inc is a Mansfield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We are dedicated to investing in highly innovative, early stage biotechnology companies. We are focused on supporting the development of novel therapeutics for unmet medical needs.
HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow`s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.